Nicorandil Eg

Nicorandil, the active ingredient in Nicorandil Eg, is a potassium channel activator presented as an oral tablet for oral use. It is used to treat chronic stable angina in adult patients.

GNH USA supplies Nicorandil Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nicorandil is indicated for conditions involving myocardial oxygen demand and supply imbalance, primarily chronic stable angina. - Chronic stable angina: reduces frequency of angina attacks and improves exercise tolerance. - Variant (Prinzmetal) angina: helps prevent coronary artery spasm. - Post‑myocardial infarction angina: may aid in symptom control when other therapies are insufficient.

Nicorandil may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Headache: mild to moderate, often transient. - Flushing: warmth and redness of the skin. - Dizziness or light‑headedness, especially on standing. - Nausea or abdominal discomfort. - Palpitations: sensation of rapid or irregular heartbeat. - Hypotension: mild drop in blood pressure.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure requiring medical attention. - Exacerbation of angina or myocardial infarction. - Ulceration or severe gastrointestinal irritation. - Allergic reactions such as rash or Stevens‑Johnson syndrome. - Syncope: sudden loss of consciousness. - Cardiogenic shock in extreme cases.

Before initiating Nicorandil therapy, several safety considerations should be observed. - Blood pressure monitoring: check baseline and periodic readings. - Concomitant nitrates: avoid combined use to prevent excessive vasodilation. - Hepatic impairment: use with caution in patients with liver dysfunction. - Severe hypotension: discontinue if symptomatic low blood pressure occurs. - Pregnancy and lactation: assess risk‑benefit; generally avoid unless clearly needed. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Nicorandil can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Other nitrate preparations: risk of profound hypotension. - Phosphodiesterase‑5 inhibitors (e.g., sildenafil): may cause severe blood pressure fall. - Potent vasodilators (e.g., hydralazine): additive hypotensive effect.

Moderate Interactions (Monitor Closely): - Antihypertensive agents (ACE inhibitors, ARBs, beta‑blockers): may enhance blood pressure lowering. - Diuretics: monitor electrolytes and volume status. - Calcium channel blockers: watch for additive vasodilatory response. - Oral hypoglycemics: possible alteration of glucose control. - Antiplatelet or anticoagulant drugs: monitor for bleeding tendency.